Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial

INTRODUCTION: Patients with ulcerative colitis (UC) regard rapid onset of action among the most important aspects of their treatment. We used the partial Mayo Clinic Score (pMCS) and component patient-reported subscores to assess the rapidity and sustainability of response to filgotinib, a once-dail...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	AMERICAN JOURNAL OF GASTROENTEROLOGY 2023-01, Vol.118 (1), p.138-147
Hauptverfasser:	Danese, Silvio, Ferrante, Marc, Feagan, Brian G, Peyrin-Biroulet, Laurent, Hibi, Toshifumi, Sandborn, William J, Schreiber, Stefan, Ritter, Timothy, Loftus, Edward V, Rogler, Gerhard, Oortwijn, Alessandra, Yun, Chohee, Le Brun, Franck-Olivier, Dinoso, Jason, Hsieh, Jeremy, Vermeire, Severine
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!